<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

• Hoofdauteurs: Ricardo D. Gonzalez (Auteur), George W. Small (Auteur), Adrian J. Green (Auteur), Farida S. Akhtari (Auteur), Alison A. Motsinger-Reif (Auteur), Julia C. F. Quintanilha (Auteur), Tammy M. Havener (Auteur), David M. Reif (Auteur), Howard L. McLeod (Auteur), Tim Wiltshire (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2023-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Oxaliplatin (OXAL) is a commonly used chemotherapy for treating colorectal cancer (CRC). A recent genome wide association study (GWAS) showed that a genetic variant (rs11006706) in the lncRNA gene <i>MKX-AS1</i> and partnered sense gene <i>MKX</i> could impact the response of...